A detailed history of Kavar Capital Partners Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 12,294 shares of EW stock, worth $805,011. This represents 0.21% of its overall portfolio holdings.

Number of Shares
12,294
Previous 13,384 8.14%
Holding current value
$805,011
Previous $1.28 Million 11.19%
% of portfolio
0.21%
Previous 0.24%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$84.3 - $94.31 $91,887 - $102,797
-1,090 Reduced 8.14%
12,294 $1.14 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $1.07 Million - $1.41 Million
-14,764 Reduced 52.45%
13,384 $1.28 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $451,038 - $568,347
7,309 Added 35.07%
28,148 $2.15 Million
Q3 2023

Nov 06, 2023

SELL
$69.28 - $93.38 $86,253 - $116,258
-1,245 Reduced 5.64%
20,839 $1.44 Million
Q2 2023

Aug 07, 2023

SELL
$81.41 - $94.33 $42,903 - $49,711
-527 Reduced 2.33%
22,084 $2.08 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $34,902 - $39,719
-470 Reduced 2.04%
22,611 $1.87 Million
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $291,641 - $373,368
-4,270 Reduced 15.61%
23,081 $1.72 Million
Q3 2022

Nov 08, 2022

BUY
$82.37 - $107.29 $17,215 - $22,423
209 Added 0.77%
27,351 $2.26 Million
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $100,599 - $149,178
1,163 Added 4.48%
27,142 $2.58 Million
Q1 2022

May 09, 2022

BUY
$101.96 - $128.34 $14,580 - $18,352
143 Added 0.55%
25,979 $3.06 Million
Q4 2021

Jan 27, 2022

BUY
$106.37 - $130.68 $51,163 - $62,857
481 Added 1.9%
25,836 $3.35 Million
Q3 2021

Nov 01, 2021

BUY
$102.91 - $122.75 $24,183 - $28,846
235 Added 0.94%
25,355 $2.87 Million
Q2 2021

Aug 02, 2021

BUY
$83.84 - $104.76 $59,945 - $74,903
715 Added 2.93%
25,120 $2.6 Million
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $11,408 - $13,147
145 Added 0.6%
24,405 $2.04 Million
Q4 2020

Feb 05, 2021

BUY
$71.69 - $91.23 $1.74 Million - $2.21 Million
24,260 New
24,260 $2.21 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Kavar Capital Partners Group, LLC Portfolio

Follow Kavar Capital Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.